FR05C0027I2 - - Google Patents
Info
- Publication number
- FR05C0027I2 FR05C0027I2 FR05C0027C FR05C0027C FR05C0027I2 FR 05C0027 I2 FR05C0027 I2 FR 05C0027I2 FR 05C0027 C FR05C0027 C FR 05C0027C FR 05C0027 C FR05C0027 C FR 05C0027C FR 05C0027 I2 FR05C0027 I2 FR 05C0027I2
- Authority
- FR
- France
- Prior art keywords
- conopeptide
- omega
- medicament
- manufacture
- disclosed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Control Of El Displays (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/496,847 US5795864A (en) | 1995-06-27 | 1995-06-27 | Stable omega conopetide formulations |
| US08/613,400 US6054429A (en) | 1996-03-08 | 1996-03-08 | Epidural method of producing analgesia |
| PCT/US1996/011041 WO1997001351A1 (en) | 1995-06-27 | 1996-06-26 | Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR05C0027I1 FR05C0027I1 (enrdf_load_stackoverflow) | 2005-08-12 |
| FR05C0027I2 true FR05C0027I2 (enrdf_load_stackoverflow) | 2006-12-29 |
Family
ID=27052304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR05C0027C Active FR05C0027I2 (enrdf_load_stackoverflow) | 1995-06-27 | 2005-06-23 |
Country Status (13)
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5931809A (en) | 1995-07-14 | 1999-08-03 | Depotech Corporation | Epidural administration of therapeutic compounds with sustained rate of release |
| JP2002509080A (ja) * | 1998-02-20 | 2002-03-26 | シンジェンタ リミテッド | グラモストラ・スパチュラタの毒から得られる鎮痛性ペプチドおよびその使用 |
| AUPP627498A0 (en) | 1998-10-02 | 1998-10-22 | University Of Queensland, The | Novel peptides - i |
| DK1572725T3 (da) | 2002-12-02 | 2012-06-18 | Xenome Ltd | Chi-conotoksinpeptider med en N-terminal pyroglutaminsyre |
| EP1578787B1 (en) | 2002-12-02 | 2012-11-14 | Xenome Ltd | Novel chi-conotoxin peptides (-ii) |
| SI1594517T1 (sl) | 2003-01-28 | 2007-10-31 | Microbia Inc | Sestavki za zdravljenje gastrointestinalnih motenj |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EP1689401A1 (en) | 2003-10-02 | 2006-08-16 | Elan Pharmaceuticals, Inc. | Method for reducing pain |
| GB0410215D0 (en) * | 2004-05-07 | 2004-06-09 | Lescroart Pol | Nerve damage |
| US8188048B2 (en) | 2006-06-23 | 2012-05-29 | Xenome Limited | Combination therapy |
| US8673856B2 (en) * | 2006-11-04 | 2014-03-18 | Anygen Co., Ltd. | Omega conotoxins |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CN101772513B (zh) | 2007-06-04 | 2013-11-13 | 协同医药品公司 | 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂 |
| WO2009135258A1 (en) * | 2008-05-06 | 2009-11-12 | Cnsbio Pty Ltd | Methods and compositions for the management of pain using omega-conotoxins |
| AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| JP5964589B2 (ja) | 2008-12-03 | 2016-08-03 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃアゴニストの製剤およびその使用方法 |
| WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| ES2657938T3 (es) | 2008-12-31 | 2018-03-07 | Ardelyx, Inc. | Compuestos y métodos para inhibir el antipuerto mediado por NHE en el tratamiento de trastornos asociados a la retención de líquidos o a la sobrecarga de sales y trastornos del tracto gastrointestinal |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| BR112015003527A2 (pt) | 2012-08-21 | 2017-07-04 | Ardelyx Inc | compostos e métodos para inibição de antiporte mediado por nhe no tratamento de desordens associadas à retenção de fluido ou sobrecarga de sal e desordens do trato gastrointestinal |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| ES2735992T3 (es) | 2013-04-12 | 2019-12-23 | Ardelyx Inc | Compuestos de unión a NHE3 y procedimientos para inhibir el transporte de fosfatos |
| PL3004138T3 (pl) | 2013-06-05 | 2024-07-29 | Bausch Health Ireland Limited | Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie |
| US11147884B2 (en) | 2017-01-09 | 2021-10-19 | Ardelyx, Inc. | Inhibitors of NHE-mediated antiport |
| KR102669987B1 (ko) | 2017-01-09 | 2024-05-31 | 알데릭스, 인코포레이티드 | 위장관 장애를 치료하는 데 유용한 화합물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3926287A1 (de) * | 1989-08-09 | 1991-02-21 | Bernhard Clasbrummel | Medizinische anwendung von omega-conotoxin gvia oder omega-conotoxin gvia-analoga zur sympathikolyse |
| US5051403A (en) * | 1989-11-22 | 1991-09-24 | Neurex Corporation | Method of treating ischemia-related neuronal damage |
| AU3074592A (en) * | 1991-11-12 | 1993-06-15 | Neurex Corporation | Compositions for delayed treatment of ischemia-related neuronal damage |
| WO1993013128A1 (en) * | 1991-12-30 | 1993-07-08 | Neurex Corporation | Methods of producing analgesia and enhancing opiate analgesia |
| JPH06247879A (ja) * | 1993-02-17 | 1994-09-06 | Bristol Myers Squibb Co | デオキシチミジンヌクレオシドを含有する注射用製剤の安定化方法およびその方法によって得られる安定化注射用製剤 |
-
1996
- 1996-06-26 DE DE69627153T patent/DE69627153T2/de not_active Expired - Lifetime
- 1996-06-26 DE DE69637021T patent/DE69637021T2/de not_active Expired - Lifetime
- 1996-06-26 DK DK96923511T patent/DK0835126T3/da active
- 1996-06-26 EP EP03007342A patent/EP1336409B1/en not_active Expired - Lifetime
- 1996-06-26 CA CA002224795A patent/CA2224795C/en not_active Expired - Fee Related
- 1996-06-26 AT AT03007342T patent/ATE359086T1/de active
- 1996-06-26 AT AT96923511T patent/ATE235914T1/de active
- 1996-06-26 AU AU64002/96A patent/AU695166B2/en not_active Ceased
- 1996-06-26 PT PT96923511T patent/PT835126E/pt unknown
- 1996-06-26 ES ES96923511T patent/ES2194998T3/es not_active Expired - Lifetime
- 1996-06-26 DE DE1996627153 patent/DE122005000043I2/de active Active
- 1996-06-26 ES ES03007342T patent/ES2283671T3/es not_active Expired - Lifetime
- 1996-06-26 DK DK03007342T patent/DK1336409T3/da active
- 1996-06-26 EP EP96923511A patent/EP0835126B1/en not_active Expired - Lifetime
- 1996-06-26 WO PCT/US1996/011041 patent/WO1997001351A1/en active IP Right Grant
- 1996-06-26 PT PT03007342T patent/PT1336409E/pt unknown
- 1996-06-27 JP JP8188120A patent/JP2838073B2/ja not_active Expired - Fee Related
-
2005
- 2005-06-23 FR FR05C0027C patent/FR05C0027I2/fr active Active
- 2005-07-06 LU LU91181C patent/LU91181I2/fr unknown
- 2005-07-13 NL NL300201C patent/NL300201I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE122005000043I2 (de) | 2006-08-03 |
| ES2194998T3 (es) | 2003-12-01 |
| AU6400296A (en) | 1997-01-30 |
| ATE359086T1 (de) | 2007-05-15 |
| PT1336409E (pt) | 2007-06-29 |
| JP2838073B2 (ja) | 1998-12-16 |
| HK1058146A1 (en) | 2004-05-07 |
| LU91181I2 (fr) | 2005-09-06 |
| ATE235914T1 (de) | 2003-04-15 |
| ES2283671T3 (es) | 2007-11-01 |
| NL300201I2 (nl) | 2006-02-01 |
| DK1336409T3 (da) | 2007-08-13 |
| EP1336409B1 (en) | 2007-04-11 |
| DE122005000043I1 (de) | 2006-06-29 |
| DE69627153D1 (de) | 2003-05-08 |
| DE69627153T2 (de) | 2003-12-04 |
| NL300201I1 (nl) | 2005-09-01 |
| DE69637021T2 (de) | 2008-01-10 |
| JPH09104634A (ja) | 1997-04-22 |
| EP0835126B1 (en) | 2003-04-02 |
| WO1997001351A1 (en) | 1997-01-16 |
| EP0835126A1 (en) | 1998-04-15 |
| AU695166B2 (en) | 1998-08-06 |
| CA2224795C (en) | 2001-04-03 |
| FR05C0027I1 (enrdf_load_stackoverflow) | 2005-08-12 |
| CA2224795A1 (en) | 1997-01-16 |
| EP1336409A1 (en) | 2003-08-20 |
| DE69637021D1 (de) | 2007-05-24 |
| DK0835126T3 (da) | 2003-07-14 |
| PT835126E (pt) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR05C0027I2 (enrdf_load_stackoverflow) | ||
| AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
| ZA969520B (en) | Use of epinastine for the treatment of pain | |
| HUP9801777A3 (en) | Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism | |
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| GB2298440B (en) | Well treatment | |
| ZA9610139B (en) | Treatment of the cns effects of hiv | |
| AU7545594A (en) | Implantable device for the treatment of aedemas | |
| GB9512290D0 (en) | Uses of polyhexanide | |
| AU6328696A (en) | Treatment of hemoglobinopathies | |
| AU1578295A (en) | Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders | |
| AU3105095A (en) | Device for ensuring that medication is taken at the correct time | |
| AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
| EP0765661A3 (en) | Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis | |
| GB9303157D0 (en) | Treatment of a group of related disorders | |
| AP9200355A0 (en) | "Therapeutic agent" | |
| HU9502623D0 (en) | Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure | |
| ZA9610433B (en) | Medical use of proteases. | |
| GB9419048D0 (en) | Treatment of muscular disorders | |
| AU7726796A (en) | Use of 3-oxa-d-prostaglandins for the manufacture of a medicament for the treatment of glaucoma | |
| ZA947912B (en) | Treatment of medical disorders associated with free radical formation | |
| SI0778025T1 (en) | Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals | |
| AU5419894A (en) | Dental treatment aid | |
| GB9505681D0 (en) | "Treatment" | |
| GB9503143D0 (en) | Treatment of depression |